FAQ/Help |
Calendar |
Search |
Today's Posts |
11-08-2016, 12:16 PM | #1 | ||
|
|||
Senior Member
|
A new initiative at Oxford University, NeuroMetrology Lab, looks interesting. They write [1]:
"Our objective is to develop ways of accurately measuring neurological disorders such as Parkinson's disease... Objective numerical measures are needed for accurate diagnosis and staging of disease, and monitoring of progression rate. They are also critically important for clinical trials, in three ways. First, a baseline stratification of patients as they enter a trial; second, detection of an early signal to guide critical go/no go decisions; and third, evaluation of trial results." Reference: [1] NeuroMetrology Lab — Nuffield Department of Clinical Neurosciences John
__________________
Born 1955. Diagnosed PD 2005. Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Quantifying or measuring TOS? | Thoracic Outlet Syndrome | |||
Watch and learn: a new tool for measuring Parkinson’s disease | Parkinson's Disease | |||
Measuring small changes in PD symptoms | Parkinson's Disease | |||
Measuring progress | Traumatic Brain Injury and Post Concussion Syndrome | |||
Measuring Muscles | ALS News & Research |